Persistent URL of this record https://hdl.handle.net/1887/3563456
Documents
-
- Download
- jco.21.01942
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
High-dose treosulfan and melphalan as consolidation therapy versus standard therapy for high-risk (metastatic) Ewing Sarcoma
- All authors
- Koch, R.; Gelderblom, H.; Haveman, L.; Brichard, B.; Jurgens, H.; Cyprova, S.; Berg, H. van den; Hassenpflug, W.; Raciborska, A.; Ek, T.; Baumhoer, D.; Egerer, G.; Eich, H.T.; Renard, M.; Hauser, P.; Burdach, S.; Bovee, J.; Bonar, F.; Reichardt, P.; Kruseova, J.; Hardes, J.; Kuhne, T.; Kessler, T.; Collaud, S.; Bernkopf, M.; Butterfass-Bahloul, T.; Dhooge, C.; Bauer, S.; Kiss, J.; Paulussen, M.; Hong, A.; Ranft, A.; Timmermann, B.; Rascon, J.; Vieth, V.; Kanerva, J.; Faldum, A.; Metzler, M.; Hartmann, W.; Hjorth, L.; Bhadri, V.; Dirksen, U.
- Date
- 2022-07-20
- Journal
- Journal of Clinical Oncology
- Volume
- 40
- Issue
- 21
- Pages
- 2307 - 2320